Impact of new ASEAN device rules will reflect impact of original directives in EU
This article was originally published in SRA
Executive Summary
The ASEAN medical device harmonization scheme that is under way is a major undertaking that will have a similar impact in the south-east Asian region as the implementation of the medical device directives had in the EU, according to senior medtech industry figure Philippe Auclair.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.